4.6 Article

Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome

Related references

Note: Only part of the references are listed.
Article Rheumatology

Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals

Lisa-Marie Mauracher et al.

Summary: Differences in neutrophil subpopulations and activation were observed between patients with APS and healthy controls, suggesting that neutrophils may play a role in thrombotic manifestations in APS. HDNs of APS patients showed higher activation compared to healthy donors, while LDNs showed higher baseline activation and lower response to stimulation but increased NET formation. Overall, these findings indicate that targeting neutrophils may be a potential strategy for preventing thrombosis in patients with APS.

RHEUMATOLOGY (2021)

Article Peripheral Vascular Disease

Myocardial Infarction in Systemic Lupus Erythematosus: Incidence and Coronary Angiography Findings

Per Tornvall et al.

Summary: The study showed an increased incidence of AMI in European SLE patients, but no indication of a higher proportion of MINOCA in these patients.

ANGIOLOGY (2021)

Review Hematology

Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review

Chunyan Cheng et al.

Summary: Thrombotic Antiphospholipid Syndrome (APS) is a condition that affects young individuals and is associated with circulating antiphospholipid antibodies. The most common clinical presentation is venous thromboembolism, while arterial thrombosis is less studied.

BLOOD REVIEWS (2021)

Article Rheumatology

Has the excess risk of acute myocardial infarction in rheumatoid arthritis relative to the general population declined? A population study of trends over time

Kiana Yazdani et al.

Summary: The study aimed to evaluate the ten-year risk of incident acute myocardial infarction (AMI) in incident rheumatoid arthritis (RA) relative to the general population. A linear Cox model was selected as the best fitting model for AMI events. RA patients were found to have a 21% higher risk of AMI compared to the general population. Both RA patients and the general population experienced a significant linear decline in the risk of AMI over time, with no difference between the two groups.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)

Review Immunology

Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review

Chiara Kirchler et al.

Summary: The study systematically reviewed the role of interferon I and fibroblast growth factor-23 in cardiovascular diseases in patients with SLE or CLE, finding an association between IFN-I and MACE, with the strongest association found for cardiac events. However, the results of the studies showed some inconsistency and bias, and there is a lack of research on CLE and FGF-23.

AUTOIMMUNITY REVIEWS (2021)

Review Cell Biology

Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction

Yonggang Ma

Summary: Neutrophils play a dual role in post-myocardial infarction, both cleaning up dead cell debris and potentially exacerbating inflammation and cardiac injury.

CELLS (2021)

Review Cardiac & Cardiovascular Systems

Neutrophils as regulators of cardiovascular inflammation

Carlos Silvestre-Roig et al.

NATURE REVIEWS CARDIOLOGY (2020)

Review Rheumatology

EULAR recommendations for the management of antiphospholipid syndrome in adults

Maria G. Tektonidou et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Review Immunology

Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form

Tamara Kolitz et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Hematology

Neutrophil Extracellular Traps in Arterial and Venous Thrombosis

Elodie Laridan et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)

Article Cardiac & Cardiovascular Systems

Fourth Universal Definition of Myocardial Infarction (2018)

Kristian Thygesen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Letter Medicine, General & Internal

Diagnosis and Management of the Antiphospholipid Syndrome

Karl J. Lackner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

White Blood Cell Subtypes Are Associated with a Greater Long-Term Risk of Death after Acute Myocardial Infarction

Arthur Shiyovich et al.

TEXAS HEART INSTITUTE JOURNAL (2017)

Article Cardiac & Cardiovascular Systems

White Blood Cell Subtypes Are Associated with a Greater Long-Term Risk of Death after Acute Myocardial Infarction

Arthur Shiyovich et al.

TEXAS HEART INSTITUTE JOURNAL (2017)

Review Cardiac & Cardiovascular Systems

Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review

Salik Nazir et al.

CORONARY ARTERY DISEASE (2017)

Review Immunology

Antiphospholipid syndrome and the heart: A case series and literature review

Gentian Denas et al.

AUTOIMMUNITY REVIEWS (2015)

Article Rheumatology

The global anti-phospholipid syndrome score in primary APS

Savino Sciascia et al.

RHEUMATOLOGY (2015)

Article Rheumatology

GAPSS: the Global Anti-Phospholipid Syndrome Score

Savino Sciascia et al.

RHEUMATOLOGY (2013)

Review Medicine, General & Internal

Association between venous and arterial thrombosis: Clinical implications

Massimo Franchini et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)

Article Medicine, General & Internal

Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction

P. Jaremo et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)